Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Elena Vega

Imaging Software at Six Medical Sites Recalled After Ruler Measurements on Ultrasound Studies Came Out Inaccurate

Regulators have posted a recall of medical imaging software after the manufacturer determined that a flaw can make ruler measurements inaccurate on the workstations radiologists use to read scans. The affected product is FUJIFILM Synapse PACS version 7.4.310, and the recall is unusually small: six systems, at sites in five states and one location in Australia.

The size is worth stating plainly at the top, because the story is easy to inflate. This is not a nationwide software failure sitting inside every hospital reading room. It is a narrow, identified defect at a handful of installations, and the manufacturer has told those sites they may continue using the system, provided staff are aware of the problem and take appropriate precautions when making a diagnosis.

Still, the category of failure is the interesting part. Measurement is how imaging becomes a decision. A number on a screen can determine whether a mass is watched or biopsied, whether a fluid collection is drained, whether a structure is called normal. Software that quietly reports the wrong distance is a different kind of defect from a machine that stops working.


A Small Recall Carrying an Outsized Lesson

The FDA device recall record lists recall number Z-3030-2026 and identifies the recalling firm as FUJIFILM Healthcare Americas Corporation of Lexington, Massachusetts. The manufacturer's stated reason is direct: a "software issue may cause the ruler measurement to be inaccurate." Regulators recorded the determined cause as software design.

FUJIFILM initiated the action on July 22 and emailed an urgent medical device correction to affected customers the day before. Regulators posted the record on August 26. The classification is Class II, the middle severity tier, which the agency uses when a product may cause temporary or medically reversible harm and serious consequences are considered unlikely.

The record lists a quantity in commerce of 6 units, with distribution in New York, Virginia, Kansas, Oregon, Ohio, and Australia. Six serial numbers are named. That figure is worth holding onto, because device recall records routinely pair a small unit count with phrasing about worldwide or nationwide distribution, which describes the geographic spread of the affected units rather than the volume of installed systems.


Measurement Errors Reach Patients Through Decisions

Synapse PACS is a picture archiving and communication system, cleared as a radiological image processing system under 510(k) number K190232. In plain terms, it is the software that stores scans and displays them to the physician who interprets them, with tools for zooming, comparing prior studies, and measuring structures.

The workaround FUJIFILM gave customers pointed to where the flaw shows up. Sites were told they could perform M-mode ruler measurements on the ultrasound system itself and then transfer the study to Synapse PACS. M-mode is an ultrasound display that tracks how a structure moves over time, used heavily in echocardiography to measure chamber size and wall motion, and in obstetric imaging to document fetal heart rate.

That narrows the practical exposure considerably. The instruction is to take the measurement on the ultrasound machine, where it is unaffected, rather than on the reading workstation. Customers were also asked to post the notification at Synapse workstations, return a field action verification form, open a service ticket, and report any known adverse events to regulators.


The Reach and the Limits of the Correction

Nothing in the record indicates a patient has been harmed, and regulators have not published any injury reports connected to the defect. Neither the agency nor the company has named the hospitals or imaging centers involved, and there is no public mechanism for a patient to learn whether their scan was read on an affected workstation or during the window before the correction was issued.

That gap is not unusual in device software corrections, and it is a fair question about transparency. The agency's public recall and alert postings are searchable, but they are written for manufacturers and hospital biomedical engineering departments rather than for the people whose scans are involved.

Six units is a very small footprint compared to the thousands of imaging workstations operating in the five named states, and no reader should assume their local hospital is affected.


Reasonable Questions for Patients Awaiting Imaging Results

Nobody should delay or cancel an imaging appointment because of this recall. The risk described is narrow, the correction is underway, and skipped or postponed imaging carries its own well-documented harms, particularly for cancer follow-up and pregnancy monitoring. Weighing a six-unit software correction against a missed diagnosis is not a close call.

Patients who have had an echocardiogram or an obstetric ultrasound and received a result that does not match their symptoms or a prior study can reasonably ask whether the measurement was repeated or verified. Asking for a comparison against earlier imaging is standard practice and does not require citing a recall.

Several questions remain open. Regulators have not said whether a corrected software version has been released, how long the affected sites will operate under the workaround, or whether the same defect exists in other Synapse versions. The recall status remains open until the correction is complete, and the searchable device recall database will reflect any change.

The honest summary is modest. A measurement bug was found, disclosed, classified, and given a workaround at six installations. The system that is supposed to catch this kind of problem appears to have caught it. The broader question the case raises is one regulators and hospitals are still working through: software now performs clinical measurement, and software defects do not announce themselves the way a broken machine does.


Key Questions Answered

What was recalled? FUJIFILM Synapse PACS software version 7.4.310, a system used to store, display, and measure medical images.

How many systems are affected? Six units, at sites in New York, Virginia, Kansas, Oregon, and Ohio, plus one location in Australia.

What is the defect? A software design issue that can make ruler measurements inaccurate, with the disclosed workaround pointing to M-mode ultrasound measurements.

Can the software still be used? The manufacturer says yes, provided that staff are aware of the issue and take appropriate precautions when making a diagnosis.

Has anyone been hurt? No injuries have been reported in the public recall record.

Can I find out if my scan was affected? Not directly. The affected sites are not publicly named, though you can ask your imaging provider whether it uses Synapse PACS.

Should I cancel an upcoming ultrasound? No. Delaying imaging carries real risks in itself, and this recall involves a very small number of installations.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.